A Germline BRCA2 Pathogenic Variant Identified by Multigene Panel Testing in Upper Tract Urothelial Carcinoma.

Matsuo K, Zennami K, Yoshida M, Hatakeyama M, Morikawa M, Hattori K, Akamatsu S

Open source

DOI
10.1002/iju5.70268
Published
2026 Sep
Container
IJU case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/iju5.70268,
  title = {A Germline BRCA2 Pathogenic Variant Identified by Multigene Panel Testing in Upper Tract Urothelial Carcinoma.},
  author = {Matsuo K and Zennami K and Yoshida M and Hatakeyama M and Morikawa M and Hattori K and Akamatsu S},
  year = {2026},
  journal = {IJU case reports},
  doi = {10.1002/iju5.70268},
  url = {https://doi.org/10.1002/iju5.70268}
}

RIS

TY  - JOUR
TI  - A Germline BRCA2 Pathogenic Variant Identified by Multigene Panel Testing in Upper Tract Urothelial Carcinoma.
AU  - Matsuo K
AU  - Zennami K
AU  - Yoshida M
AU  - Hatakeyama M
AU  - Morikawa M
AU  - Hattori K
AU  - Akamatsu S
PY  - 2026
JO  - IJU case reports
DO  - 10.1002/iju5.70268
UR  - https://doi.org/10.1002/iju5.70268
ER  - 

APA

K, M., K, Z., M, Y., M, H., M, M., K, H., & S, A. (2026). A Germline BRCA2 Pathogenic Variant Identified by Multigene Panel Testing in Upper Tract Urothelial Carcinoma.. IJU case reports. https://doi.org/10.1002/iju5.70268

Source records